Literature DB >> 15112176

Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease.

Orhan Kocaman1, Huseyin Oflaz, Ensar Yekeler, Memduh Dursun, Dogan Erdogan, Seref Demirel, Sabahat Alisir, Faruk Turgut, Fehmi Mercanoglu, Tevfik Ecder.   

Abstract

BACKGROUND: Cardiovascular problems are a major cause of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Endothelial dysfunction (ED) and intima-media thickness (IMT) are predictors for the development and progression of atherosclerosis. In the present study, ED and IMT were investigated in patients with ADPKD.
METHODS: Fifteen hypertensive and 16 normotensive patients with ADPKD with preserved renal function, 16 patients with essential hypertension, and 24 healthy subjects were included in the study. Endothelial function of the brachial artery was evaluated by means of high-resolution vascular ultrasound. Endothelial-dependent dilatation (EDD) was assessed by establishing reactive hyperemia, and endothelial-independent dilatation was determined by using sublingual isosorbide dinitrate. Carotid IMT was measured by means of high-resolution vascular ultrasound.
RESULTS: EDD was significantly worse in hypertensive patients with ADPKD compared with patients with essential hypertension (9.1% +/- 4.1% versus 12.4% +/- 4.6%; P < 0.05) and even in normotensive patients with ADPKD compared with healthy subjects (13.1% +/- 5.2% versus 18.1% +/- 8.1%; P < 0.01). Moreover, carotid IMT was significantly greater in both hypertensive (0.71 +/- 0.10 mm; P < 0.01) and normotensive (0.57 +/- 0.14 mm; P < 0.001) patients with ADPKD compared with healthy subjects (0.45 +/- 0.10 mm).
CONCLUSION: Both hypertensive and normotensive patients with ADPKD show significant ED and increased IMT, which are predictors of atherosclerosis.

Entities:  

Mesh:

Year:  2004        PMID: 15112176     DOI: 10.1053/j.ajkd.2004.01.011

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  28 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

2.  Primary cilia regulates the directional migration and barrier integrity of endothelial cells through the modulation of hsp27 dependent actin cytoskeletal organization.

Authors:  Thomas J Jones; Ravi K Adapala; Werner J Geldenhuys; Chris Bursley; Wissam A AbouAlaiwi; Surya M Nauli; Charles K Thodeti
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.

Authors:  Kristen L Nowak; Berenice Gitomer; Heather Farmer-Bailey; Wei Wang; Mikaela Malaczewski; Jelena Klawitter; Zhiying You; Diana George; Nayana Patel; Anna Jovanovich; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2019-02-23       Impact factor: 8.860

4.  Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.

Authors:  Kristen L Nowak; Heather Farmer; Melissa A Cadnapaphornchai; Berenice Gitomer; Michel Chonchol
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

Review 5.  Hypertension in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; Konrad Stepniakowski; Frederic Rahbari-Oskoui
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 6.  Flow-mediated dilation stimulated by sustained increases in shear stress: a useful tool for assessing endothelial function in humans?

Authors:  Joshua C Tremblay; Kyra E Pyke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

Review 7.  Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Jill Norman
Journal:  Biochim Biophys Acta       Date:  2011-07-01

8.  Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

Authors:  Ladan Zand; Vicente E Torres; Timothy S Larson; Bernard F King; Sanjeev Sethi; Eric J Bergstralh; Andrea Angioi; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2015-11-27       Impact factor: 5.992

9.  Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.

Authors:  Kultigin Turkmen; Huseyin Oflaz; Bora Uslu; Arif O Cimen; Ali Elitok; Erdem Kasikcioglu; Sabahat Alisir; Fatih Tufan; Sule Namli; Mukremin Uysal; Tevfik Ecder
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 8.237

10.  Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Jelena Klawitter; Kim McFann; Alexander T Pennington; Wei Wang; Jost Klawitter; Uwe Christians; Robert W Schrier; Berenice Gitomer; Melissa A Cadnapaphornchai
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-29       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.